# Ultraleap

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ultraleap

- Industry: Consumer Products
- Headquarters: Bristol, UK
- Website: www.ultraleap.com
- Total disclosed funding: $219M
- Latest round: Series D (Nov 17, 2021)
- Investors on record: 9

## About

Ultraleap Limited focuses on enhancing digital interactions through innovative haptic feedback and hand tracking technologies, providing solutions that improve user engagement across various industries including gaming and virtual reality.Founded in 2013 in Bristol, UK, Ultraleap Limited specializes in developing advanced hand tracking and haptic technologies. The company has successfully completed 9 deals, with the most recent funding round being a Series D in November 2021, where it raised GBP 60 million led by British Patient Capital and other prominent investors. The company was co-founded by Benjamin Long and Tom Carter, who have experience in similar ventures. Tom Carter currently serves as the CEO.Ultraleap specializes in technology that enhances user interaction within digital environments, focusing on haptic feedback and advanced hand tracking solutions. The company offers software development kits (SDKs) for haptics and hand tracking, allowing seamless integration into various applications. Key products include the Leap Motion Controller 2 and the Haptics Development Kit, which are utilized across industries such as virtual reality, gaming, and training simulations. Ultraleap's client base spans globally, targeting markets in North America, Europe, and Asia, with a particular focus on businesses that seek to innovate user interfaces through advanced interaction technologies.In 2022, Ultraleap reported a revenue of GBP 5,527,561. The company's revenue primarily comes from direct sales and partnerships, particularly through flagship products like the Leap Motion Controller 2 and Haptics Development Kit, marketed to B2B clients and developers in the VR and gaming sectors. This includes licensing agreements for their SDKs, enabling clients to incorporate Ultraleap's technology into their applications.Following its Series D funding round in November 2021, Ultraleap plans to allocate the GBP 60 million raised towards enhancing research and development initiatives and expanding its product offerings. The company aims to launch new products that leverage its existing technology and capture emerging market opportunities, particularly in North America and Asia. By investing in advanced tools and technologies, Ultraleap seeks to strengthen its position in the market and enhance its product suite to meet evolving consumer demands.

## Funding rounds

- Series D, Nov 17, 2021, $81M — Longview Innovation, Tencent Investment, CMB International Asset Management, Mayfair Equity Partners, British Patient Capital
- Series D, Jun 18, 2021, $51M — Tencent Investment
- Series C, Nov 30, 2018, $45M — Hostplus, Longview Innovation, Dolby Family Ventures, Woodford Patient Capital Trust, Mayfair Equity Partners, Cornes Technologies Limited
- Series B, May 2, 2017, $23M — Longview Innovation, Dolby Family Ventures, Woodford Patient Capital Trust, Cornes Technologies Limited
- Series A, Oct 28, 2015, $17M — Longview Innovation, Woodford Patient Capital Trust
- Seed, Oct 7, 2014, $1.2M — Longview Innovation

## Investors

- Longview Innovation (https://capitalatlas.ai/funds/longview-innovation) — Seed, Series A, Series B, Series C, Series D
- Woodford Patient Capital Trust — Series A, Series B, Series C
- Dolby Family Ventures (https://capitalatlas.ai/funds/dolby-family-ventures) — Series B, Series C
- Cornes Technologies Limited — Series B, Series C
- Hostplus — Series C
- Mayfair Equity Partners (https://capitalatlas.ai/funds/mayfair-equity-partners) — Series C, Series D
- Tencent Investment — Series D
- CMB International Asset Management (https://capitalatlas.ai/funds/cmb-international-asset-management) — Series D
- British Patient Capital — Series D